FORTE BIOSCIENCES, INC. Cash, Cash Equivalents, and Short-term Investments
FORTE BIOSCIENCES, INC. (FBRX) had Cash, Cash Equivalents, and Short-term Investments of $198.50 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashCashEquivalentsAndShortTermInvestments · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, and Short-term Investments $198.50M.
- 2024-12-31: Cash, Cash Equivalents, and Short-term Investments $58.40M.
- 2019-12-31: Cash, Cash Equivalents, and Short-term Investments $21.80M.
- 2019-09-30: Cash, Cash Equivalents, and Short-term Investments $55.30M.
| Period end | Cash, Cash Equivalents, and Short-term Investments |
|---|---|
| 2026-06-30 | $198.50M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $58.40M 10-K · filed 2025-03-28 |
| 2019-12-31 | $21.80M 10-K · filed 2020-02-27 |
| 2019-09-30 | $55.30M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $68.30M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $80.10K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $96.10M 10-K · filed 2019-02-27 |
| 2018-09-30 | $79.80M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $79.50M 10-Q · filed 2018-08-09 |